Organogenesis Holdings Inc. Class A Common Stock
ORGO
ORGO: Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
moreShow ORGO Financials
Recent trades of ORGO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ORGO's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Oral tissue regeneration and repair Oct. 10, 2017
-
Patent Title: Tissue repair fabric Mar. 22, 2011
-
Patent Title: Method and apparatus for inducing controlled mechanical constraints in a tissue construct Mar. 15, 2011
-
Patent Title: Bioengineered tissue constructs and methods for producing and using thereof Nov. 02, 2010
Federal grants, loans, and purchases
Followers on ORGO's company Twitter account
Number of mentions of ORGO in WallStreetBets Daily Discussion
Recent insights relating to ORGO
Recent picks made for ORGO stock on CNBC
ETFs with the largest estimated holdings in ORGO
Flights by private jets registered to ORGO